Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

Seven Fleet Capital Management LP 13F Holdings -- Portfolio & Top Positions (2026-06-30)

Seven Fleet Capital Management LP (CIK 2092021) reported $605.9M across 96 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: CGON ($134.0M, 22.12%), TNGX ($95.7M, 15.79%), RVMD ($45.3M, 7.48%), PHVS ($26.8M, 4.42%), LQDA ($20.5M, 3.38%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1CGONCG ONCOLOGY INC$134.0M22.12%1.9MAdded
2TNGXTANGO THERAPEUTICS INC$95.7M15.79%3.2MAdded
3RVMDREVOLUTION MEDICINES INC$45.3M7.48%242,029Added
4PHVSPHARVARIS N V$26.8M4.42%774,501Added
5LQDALIQUIDIA CORPORATION$20.5M3.38%256,603Added
6ELVNENLIVEN THERAPEUTICS INC$18.5M3.06%365,386Added
7ABVXABIVAX SA$14.8M2.45%111,334Added
8AVTXAVALO THERAPEUTICS INC$14.2M2.35%770,765Added
9MIRMMIRUM PHARMACEUTICALS INC$12.9M2.13%110,393New
10ASMBASSEMBLY BIOSCIENCES INC$11.9M1.96%433,147Added
11IPSCCENTURY THERAPEUTICS INC$10.7M1.76%4.3MAdded
12CYTKCYTOKINETICS INC$10.1M1.66%118,240Added
13TSHATAYSHA GENE THERAPIES INC$9.9M1.64%1.5MAdded
14MANEVERADERMICS INC$9.8M1.62%80,000New
15AVBPARRIVENT BIOPHARMA INC$8.6M1.41%246,606Added
16TARSTARSUS PHARMACEUTICALS INC$7.9M1.31%117,067Added
17ROIVROIVANT SCIENCES LTD$7.8M1.29%220,126Added
18XNCRXENCOR INC$7.8M1.29%368,305Added
19DMRADAMORA THERAPEUTICS INC$7.4M1.22%284,430Added
20AXSMAXSOME THERAPEUTICS INC$7.1M1.16%28,826Added
21DFTXDEFINIUM THERAPEUTICS INC$7.0M1.15%148,647Added
22DNTHDIANTHUS THERAPEUTICS INC$6.3M1.04%64,723Added
23COGTCOGENT BIOSCIENCES INC$5.7M0.94%147,510Trimmed
24ERASERASCA INC$5.6M0.93%308,007Added
25NERVMINERVA NEUROSCIENCES INC$5.6M0.92%1.0MAdded

Source: SEC Form 13F filings · as of 2026-06-30